Please enable javascript to view this page correctly. Perhaps restart your browser or check to see it is not being blocked for this site.


Aniracetam vs PRL-8-53

Aniracetam vs PRL-8-53 Comparison, Similarities & Differences

Aniracetam

Read full Aniracetam Review

PRL-8-53

Read our Aniracetam Review

Aniracetam is a nootropic supplement under the racetam class that is regarded as being significantly more powerful than Piracetam. In addition to the cognitive enhancement it provides, it also acts as an anxiolytic and improves mood, memory and focus. This is likely achieved through its effects on the D2 dopamine receptors, acetylcholine receptors, and 5-HT2A receptors. However, it is still under investigational usage for treating various neurodegenerative disorders. It also has an effect on the AMPA receptor and is a drug that is thought to offer benefits for individuals with neurodegenerative disorders. Throughout European countries, it can be obtained as a prescription drug, but has never received any approval by the FDA for usage in the U.S. Aniracetam is fat soluble.



PRL-8-53 is a compound that was originally developed in the early 1970s by chemistry professor Nikolaus Hansl at Creighton University. It was initially patented and most researches were also conducted by the patent-holder. Preliminary findings indicated that ingestion of this substance resulted in better word recall after a memorization task. Also, PRL-8-53 has been shown to improve speed of solving math problems, geometric patterns, and verbal abilities. It also displays cholinergic properties, and potentiates dopamine while inhibiting serotonin.

Tradenames

1-p-anisoyl-2-pyrrilidinone, Ro 13-5057, CAS 72432-10-1, 14-methoxybenzoyl-2-pyrrolidinone, Draganon, Sarpul, Ampamet, Memodrin, Referan





Methyl 3-2-benzylmethylaminoethylbenzoate

Dose

1,500 mg/day broken into doses of two or as needed.

No dosage data available





0.05-1.2mg/kg

No dosage data available

Side Effects

The most notable side effect of Aniracetam is headaches.








Classification









Total Users


There are no users taking this supplement.









There are no users taking this supplement.


Rated


4.00/5 based on 9 user votes








n/a

Evidence-Based Effects


  • Anxiety - Decreased
  • Cognition - Increased
  • Depression - Decreased
  • Memory - Increased







  • Memory - Increased
  • Working Memory - Increased

Duration




No data available

Medical Conditions




No data available

Medical Symptoms




No data available

Purpose




No data available

Commonly Paired With




No data available

Price & Brand





Editors RecommendationCertified Pick:
PRL-8-53

Buy PRL-8-53 Single Detail Page Misc
Buy PRL-8-53

Compare Your Own










Compare